Baker Hughes Incorporated (NYSE:BHI) announced that Adam B. Anderson will be appointed Baker Hughes' vice president, investor relations effective July 1, 2011. In this position, he will be located in Houston and will report to Peter A. Ragauss, senior vice president and chief financial officer. Adam will succeed Gary R. Flaharty, who will assume a senior role in Baker Hughes' supply chain organization effective August 1, 2011.
Baker Hughes Incorporated supplies wellbore related products, and technology services and systems for drilling, formation evaluation, completion and production, and reservoir technology and consulting to the oil and natural gas industry worldwide.
POWER 3 MEDICAL PROD (PWRM)
Breast Cancer is one of the most common cancers among women. This type of cancer effects women all over the world. Most of the women having this cancer are affected by their health, emotional conditions, even losing their lives. We can not change the risks factors such as age, race and family history.
Breast cancer is a group of rapidly reproducing, undifferentiated cells in the area of the breast in women. The earliest changes occur in the epithelial cells of the terminal end buds (TEB) of the breast milk ductal system. While the outlining steps of breast cancer are unknown, the cells in the breast trigger a reaction of cell reproduction. These new cancer cells form tumors. If cancer cells are active or are considered malign, the tumor grows at tremendous speeds, and may end up in metastasis.
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease). Power3 Medical applies proprietary methodologies to discover and identify protein biomarkers associated with diseases.
Power 3 Medical Products' BC-SeraPro is a blood serum test designed to diagnose breast cancer in individuals. The test is based on proteomic technology in which a blood serum sample drawn from a patient will monitor the concentration of each protein biomarker residing in a panel of blood serum protein biomarkers to determine if a patient has breast cancer. The biomarkers in the panel have been selected for their ability to discriminate breast cancer patients from non-cancerous patients.
For more information please visit official website of PWRM:http://www.power3medical.com.
Crown Equity Holdings Inc. (CRWE)
Crown Equity Holdings Inc. (CRWE), together with its digital network, currently provides electronic media services specializing in online publishing, which brings together targeted audiences and advertisers.
Online marketing also known as internet marketing is the most simple and the most cost effective way of promoting your business. Online promotion is the quickest method to get the information to your potential clients. Online Marketing is the most cost efficient ways, which if executed in the right ways, guarantee prolific benefit to the business houses. However, it is the responsibility of the business owners to gain some first hand insight in web marketing strategies before implementing the same for their businesses.
Crown Equity Holdings Inc. (CRWE) offers internet media-driven advertising services, which covers and connects a range of marketing specialties, as well as search engine optimization for clients interested in online media awareness.
Crown Equity Holdings Inc. (CRWE) recently announced that it has extended its CRWENEWSWIRE global platform web presence and is now publishing online news and information to the following countries: Argentina, Australia, Brazil, China, France, Germany, India, Ireland, Italy, Japan, Malaysia, Mexico, New Zealand, Russia, Singapore, South Africa, South Korea, Spain, Taiwan, United Arab Emirates and the United Kingdom, using their specific country code domain and native language.
"In addition to publishing to the mentioned countries, Crown Equity Holdings Inc. has also established online publishing sites for over 660 various cities within those countries," stated Arnulfo Saucedo-Bardan, Chairman of the Board for Crown Equity Holdings Inc.
For more information please visit official website of CRWE:http://www.crownequityholdings.com
Hess Corporation (NYSE:HES) announced that it will hold a conference call on Wednesday, July 27, at 10 a.m. Eastern Daylight Time to discuss its second quarter 2011 earnings release. To phone into the conference call, parties in the United States should dial 1-866-770-7129 and enter the pass code 18188138 after 9:45 a.m. Outside the United States, parties should dial 1-617-213-8067 and enter the pass code 18188138. This conference call will also be accessible by webcast at www.hess.com (audio only).
Hess Corporation and its subsidiaries operate as an integrated energy company. It operates in two segments, Exploration and Production (E&P) and Marketing and Refining (M&R).
General Dynamics Corporation (NYSE:GD) announced that Daniel G. Clare, 52, will become president of its Jet Aviation business unit on July 1. Clare will report to Joseph T. Lombardo, executive vice president of General Dynamics' Aerospace group. Clare, a vice president of General Dynamics Corp., will succeed Peter G. Edwards, who announced his departure from Jet Aviation on June 20.
General Dynamics Corporation provides business aviation; combat vehicles, weapons systems, and munitions; shipbuilding design and construction; and information systems, technologies, and services worldwide.
CRWESelect, a stock highlight publication is pleased to alert investors of stocks on the move.
Sign Up for our Free Stock Newsletter at http://www.crweselect.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWESelect.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer( http://crweselect.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWESelect.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).